A Multicenter, Randomized, Double-blind, Active-controlled, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Versus Monotherapy of DW5421A in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Latest Information Update: 10 Mar 2026
At a glance
- Drugs Ezetimibe/pitavastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Registrational; Therapeutic Use
- Sponsors Daewon Pharmaceutical
Most Recent Events
- 10 Mar 2026 New trial record